{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T21:08:08Z","timestamp":1778965688323,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.eimce.2021.02.014","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T08:06:04Z","timestamp":1669881964000},"page":"562-567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology and in vitro antimicrobial susceptibility of aerobic Actinomycetales in a clinical setting"],"prefix":"10.1016","volume":"40","author":[{"given":"Llanos","family":"Salar-Vidal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Mart\u00edn-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Mac\u00edas-Valcayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Ponz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimce.2021.02.014_bib0100","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.DMIH2-0021-2015","article-title":"Aerobic actinomycetes of clinical significance","volume":"4","author":"Mochon","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.eimce.2021.02.014_bib0105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.micpath.2017.11.012","article-title":"Nocardiosis from 1888 to 2017","volume":"114","author":"Fatahi-Bafghi","year":"2018","journal-title":"Microb Pathog"},{"key":"10.1016\/j.eimce.2021.02.014_bib0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1201-9712(03)90102-0","article-title":"Nocardiosis: a review","volume":"7","author":"Corti","year":"2003","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.eimce.2021.02.014_bib0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/CMR.19.2.259-282.2006","article-title":"Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy","volume":"19","author":"Brown-Elliott","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimce.2021.02.014_bib0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1086\/345907","article-title":"Clinical experience with linezolid for the treatment of Nocardia infection","volume":"36","author":"Moylett","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2021.02.014_bib0125","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/cid\/cix124","article-title":"Outcome and treatment of nocardiosis after solid organ transplantation: new insights from a European study","volume":"64","author":"Lebeaux","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2021.02.014_bib0130","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1309\/AJCPW84AFTUWMHYU","article-title":"Nocardiosis in 132 patients with cancer: microbiological and clinical analyses","volume":"142","author":"Wang","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.eimce.2021.02.014_bib0135","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/JCM.02128-15","article-title":"Evaluation of matrix-assisted laser desorption ionization\u2212time of flight mass spectrometry for identification of Mycobacterium species, Nocardia species, and other aerobic actinomycetes","volume":"54","author":"Buckwalter","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimce.2021.02.014_bib0140","first-page":"754","article-title":"Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain","volume":"72","author":"Valdezate","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimce.2021.02.014_bib0145","series-title":"Susceptibility testing of Mycobacteria, Nocardiae and other aerobic actinomycetes [Internet]","author":"Woods","year":"2011"},{"key":"10.1016\/j.eimce.2021.02.014_bib0150","article-title":"The complexities of Nocardia taxonomy and identification","volume":"56","author":"Conville","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimce.2021.02.014_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2018.06.014","article-title":"Identification of Nocardia species from clinical isolates using MALDI-TOF mass spectrometry","volume":"24","author":"Mar\u00edn","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimce.2021.02.014_bib0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.diagmicrobio.2016.09.024","article-title":"Routine identification of Nocardia species by MALDI-TOF mass spectrometry","volume":"87","author":"Girard","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.eimce.2021.02.014_bib0165","first-page":"8","article-title":"Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF) score algorithm for identification of Gordonia species","author":"Ercibengoa Arana","year":"2018","journal-title":"AMB Express"},{"key":"10.1016\/j.eimce.2021.02.014_bib0170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41426-018-0083-4","article-title":"MALDI-TOF MS for identification of Tsukamurella species: Tsukamurella tyrosinosolvens as the predominant species associated with ocular infections","volume":"7","author":"Teng","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.eimce.2021.02.014_bib0175","doi-asserted-by":"crossref","first-page":"e0147487","DOI":"10.1371\/journal.pone.0147487","article-title":"Accurate identification of common pathogenic Nocardia species: Evaluation of a multilocus sequence analysis platform and matrix-assisted laser desorption ionization-time of flight mass spectrometry","volume":"11","author":"Xiao","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.eimce.2021.02.014_bib0180","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.eimc.2009.02.008","article-title":"Epidemiolog\u00eda y manifestaciones cl\u00ednicas de la infecci\u00f3n por especies de Nocardia en Tarragona, 1997 a 2008: Nocardia cyriacigeorgica es un pat\u00f3geno emergente","volume":"27","author":"Portol\u00e1","year":"2009","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimce.2021.02.014_bib0185","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jgar.2019.06.018","article-title":"Antimicrobial susceptibility profiles and species distribution of medically relevant Nocardia species: results from a large tertiary laboratory in Australia","volume":"20","author":"Tan","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.eimce.2021.02.014_bib0190","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1086\/657399","article-title":"Antimicrobial-resistant Nocardia isolates United States, 1995\u20132004","volume":"51","author":"Uhde","year":"2010","journal-title":"Clin Infect Dis"}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X22002374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X22002374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:21:07Z","timestamp":1778962867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X22002374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2529993X22002374"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2021.02.014","relation":{},"ISSN":["2529-993X"],"issn-type":[{"value":"2529-993X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and in vitro antimicrobial susceptibility of aerobic Actinomycetales in a clinical setting","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2021.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}